Maybe I can just comment that I would agree with those comments entirely, that we're not trying to protect physicians' prescribing patterns from being analyzed in order to cause improvements to the system. We're very open to peer review or having regulatory authorities look at making sure that physicians are practising at a good level of care. What we would like to see restricted is the selling of those prescription patterns for commercial interests. We feel it's important for them to be available for furthering and improving the system. For secondary commercial interests is where we would see this. We would worry that patients—
On December 13th, 2006. See this statement in context.